Published TCIMAIL newest issue No.197 | New tool "TCI SpectraViewer" | [Product Highlights] Chemiluminescent Reagents for... | Product Document Searching Made Easy by 2D Code!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 7689-03-4 | Product Number: C1495
(S)-(+)-Camptothecin
×
![]()
×
Purity: >97.0%(HPLC)
Synonyms:
Product Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 100MG |
₹6,300.00
|
3 | 39 |
|
| 1G |
₹25,200.00
|
4 | ≥40 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | C1495 |
| Purity / Analysis Method | >97.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__0H__1__6N__2O__4 = 348.36 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image), 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 7689-03-4 |
| Reaxys Registry Number | 6075662 |
| PubChem Substance ID | 87566492 |
| Merck Index (14) | 1735 |
| MDL Number | MFCD00081076 |
Specifications
| Appearance | White to Yellow to Green powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
| Specific rotation [a]20/D | +37.0 to +42.0 deg(C=0.4, CHCl3:MeOHl=8:2) |
Properties (reference)
| Specific Rotation | 40° (C=0.4,CHCl3:MeOH=8:2) |
| Solubility (soluble in) | Chloroform, Methanol |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 : Toxic if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
Related Laws:
| RTECS# | UQ0492000 |
Transport Information:
| UN Number | UN1544 |
| Class | 6.1 |
| Packing Group | III |
Application
Adeno-associated virus vector transduction enhancer
Camptothecin increases transduction by adeno-associated virus (AAV) vectors.1)
References
- 1) DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors
Application
Camptothecin: The First Identified Topoisomerase-I Inhibitor
Camptothecin (CPT), a plant alkaloid with antitumor activity, was first isolated by Wall et al. in 1966 from the Chinese tree, Camptotheca acuminate. CPT shows strong anticancer activity against a wide range of experimental tumors, but also low water solubility and high toxicity (myelosuppression and hemorrhagic cystitis). Because of these disadvantages, various CPT derivatives have been discovered such as irinotecan hydrochloride [I0714] and topotecan. Camptotecin and its derivatives interfere with DNA synthesis by inhibiting the enzyme topoisomerase-I. In order to prevent and correct of topological problems caused by the DNA double helix, topoisomerase-I catalyzes the relaxation of negatively supercoiled DNA, the knotting and unknotting DNA and the linking complementary rings of single-stranded DNA into double-stranded rings. Then the inhibition action induces breaks in single strand DNA. Eventually, this leads to double-strand DNA breaks and apoptosis or cell death. (The product is for research purpose only.)
References
- Plant antitumor agents. I. Isolation and structure of camtothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata
- Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
- Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity
- Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme (a review)
- Camptothecin: current perspectives (a review)
- Topoisomerase I inhibitors: camptothecins and beyond (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.